Twist Bioscience Corp Stock Performance

TWST Stock  USD 49.11  1.45  3.04%   
Twist Bioscience holds a performance score of 22 on a scale of zero to a hundred. The entity has a beta of 2.72, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Twist Bioscience will likely underperform. Use Twist Bioscience Corp maximum drawdown, as well as the relationship between the skewness and day typical price , to analyze future returns on Twist Bioscience Corp.

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Twist Bioscience Corp are ranked lower than 22 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively abnormal basic indicators, Twist Bioscience unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more

Actual Historical Performance (%)

One Day Return
3.04
Five Day Return
1.66
Year To Date Return
51.62
Ten Year Return
250.79
All Time Return
250.79
1
Disposition of 822 shares by Robert Werner of Twist Bioscience at 28.7095 subject to Rule 16b-3
11/24/2025
2
Disposition of 230 shares by Robert Werner of Twist Bioscience at 32.878 subject to Rule 16b-3
12/08/2025
3
Disposition of 1605 shares by Emily Leproust of Twist Bioscience at 34.556 subject to Rule 16b-3
12/22/2025
4
Disposition of 2738 shares by Adam Laponis of Twist Bioscience at 35.261 subject to Rule 16b-3
01/09/2026
5
Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 Revenue
01/12/2026
6
Disposition of 269 shares by Dennis Cho of Twist Bioscience at 25.76 subject to Rule 16b-3
01/28/2026
7
Twist Bioscience Q1 2026 Earnings Preview
01/30/2026
8
Disposition of 853 shares by Paula Green of Twist Bioscience at 31.75 subject to Rule 16b-3
02/02/2026
9
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635
02/03/2026
10
Twist Bioscience Raises Outlook As AI DNA Demand Builds Profit Focus
02/04/2026
11
Acquisition by Johannessen Jan of 5095 shares of Twist Bioscience subject to Rule 16b-3
02/05/2026
12
Twist Bioscience Launches Next-Generation Library Preparation Kits Powered by Proprietary Enzymes
02/10/2026
13
Disposition of 5000 shares by Dennis Cho of Twist Bioscience at 49.93 subject to Rule 16b-3
02/11/2026
14
Twist Bioscience Valuation Check After New Sequencing Kits Expand Genomics Offering
02/13/2026
Begin Period Cash Flow226.3 M
Total Cashflows From Investing Activities-24.8 M

Twist Bioscience Relative Risk vs. Return Landscape

If you would invest  2,646  in Twist Bioscience Corp on November 16, 2025 and sell it today you would earn a total of  2,265  from holding Twist Bioscience Corp or generate 85.6% return on investment over 90 days. Twist Bioscience Corp is currently generating 1.0901% in daily expected returns and assumes 3.8565% risk (volatility on return distribution) over the 90 days horizon. In different words, 34% of stocks are less volatile than Twist, and 79% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Twist Bioscience is expected to generate 5.01 times more return on investment than the market. However, the company is 5.01 times more volatile than its market benchmark. It trades about 0.28 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.13 per unit of risk.

Twist Bioscience Target Price Odds to finish over Current Price

The tendency of Twist Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 49.11 90 days 49.11 
under 4
Based on a normal probability distribution, the odds of Twist Bioscience to move above the current price in 90 days from now is under 4 (This Twist Bioscience Corp probability density function shows the probability of Twist Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.72 . This usually implies as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Twist Bioscience will likely underperform. Additionally Twist Bioscience Corp has an alpha of 0.6085, implying that it can generate a 0.61 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Twist Bioscience Price Density   
       Price  

Predictive Modules for Twist Bioscience

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Twist Bioscience Corp. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Twist Bioscience's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
44.9248.7852.64
Details
Intrinsic
Valuation
LowRealHigh
46.3850.2454.10
Details
12 Analysts
Consensus
LowTargetHigh
45.4049.8955.38
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.49-0.49-0.49
Details

Twist Bioscience Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Twist Bioscience is not an exception. The market had few large corrections towards the Twist Bioscience's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Twist Bioscience Corp, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Twist Bioscience within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.61
β
Beta against Dow Jones2.72
σ
Overall volatility
6.89
Ir
Information ratio 0.18

Twist Bioscience Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Twist Bioscience for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Twist Bioscience Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Twist Bioscience appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 376.57 M. Net Loss for the year was (77.67 M) with profit before overhead, payroll, taxes, and interest of 202.13 M.
Twist Bioscience Corp currently holds about 504.97 M in cash with (47.63 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.93.
Twist Bioscience has a strong financial position based on the latest SEC filings
Over 99.0% of the company shares are owned by institutional investors
Latest headline from simplywall.st: Twist Bioscience Valuation Check After New Sequencing Kits Expand Genomics Offering

Twist Bioscience Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Twist Stock often depends not only on the future outlook of the current and potential Twist Bioscience's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Twist Bioscience's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding59.8 M
Cash And Short Term Investments232.4 M

Twist Bioscience Fundamentals Growth

Twist Stock prices reflect investors' perceptions of the future prospects and financial health of Twist Bioscience, and Twist Bioscience fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Twist Stock performance.

About Twist Bioscience Performance

Assessing Twist Bioscience's fundamental ratios provides investors with valuable insights into Twist Bioscience's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Twist Bioscience is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 50.11  57.38 
Return On Tangible Assets(0.14)(0.13)
Return On Capital Employed(0.22)(0.23)
Return On Assets(0.12)(0.11)
Return On Equity(0.19)(0.20)

Things to note about Twist Bioscience Corp performance evaluation

Checking the ongoing alerts about Twist Bioscience for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Twist Bioscience Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Twist Bioscience appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 376.57 M. Net Loss for the year was (77.67 M) with profit before overhead, payroll, taxes, and interest of 202.13 M.
Twist Bioscience Corp currently holds about 504.97 M in cash with (47.63 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.93.
Twist Bioscience has a strong financial position based on the latest SEC filings
Over 99.0% of the company shares are owned by institutional investors
Latest headline from simplywall.st: Twist Bioscience Valuation Check After New Sequencing Kits Expand Genomics Offering
Evaluating Twist Bioscience's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Twist Bioscience's stock performance include:
  • Analyzing Twist Bioscience's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Twist Bioscience's stock is overvalued or undervalued compared to its peers.
  • Examining Twist Bioscience's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Twist Bioscience's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Twist Bioscience's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Twist Bioscience's stock. These opinions can provide insight into Twist Bioscience's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Twist Bioscience's stock performance is not an exact science, and many factors can impact Twist Bioscience's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Additional Tools for Twist Stock Analysis

When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.